Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oncocyte Corporation - Common Stock (NQ:OCX)

3.200 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.200
Bid (Size) 3.080 (1)
Ask (Size) 3.240 (1)
Prev. Close 3.200
Today's Range 3.200 - 3.200
52wk Range 1.922 - 4.750
Shares Outstanding 13,368,387
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OCX Stock Earnings: OncoCyte Beats EPS, Misses Revenue for Q2 2024
OCX stock results show that OncoCyte beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
Via AB Newswire

Performance

YTD
+37.3%
+37.3%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+3.2%
+3.2%
1 Year
+6.0%
+6.0%

More News

Read More
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
Via News Direct
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
Via TheNewswire.com
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Earnings Scheduled For May 12, 2025
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 24, 2025
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
What to Expect from OncoCyte's Earnings
Via Benzinga
4 Analysts Assess OncoCyte: What You Need To Know
Via Benzinga
3 Penny Stocks That Insiders Are Buying
Via MarketBeat
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Top 3 Health Care Stocks That May Collapse In Q2
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Earnings Scheduled For April 12, 2024
Via Benzinga
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Oncocyte Corporation - Common Stock publicly traded?
Yes, Oncocyte Corporation - Common Stock is publicly traded.
What exchange does Oncocyte Corporation - Common Stock trade on?
Oncocyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Oncocyte Corporation - Common Stock?
The ticker symbol for Oncocyte Corporation - Common Stock is OCX on the Nasdaq Stock Market
What is the current price of Oncocyte Corporation - Common Stock?
The current price of Oncocyte Corporation - Common Stock is 3.200
When was Oncocyte Corporation - Common Stock last traded?
The last trade of Oncocyte Corporation - Common Stock was at 06/17/25 04:00 PM ET
What is the market capitalization of Oncocyte Corporation - Common Stock?
The market capitalization of Oncocyte Corporation - Common Stock is 42.78M
How many shares of Oncocyte Corporation - Common Stock are outstanding?
Oncocyte Corporation - Common Stock has 43M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.